We've had a lot of "unprecedented" things happen in the past year in the Stock Market, but last week's wild short squeeze showdown sure takes the cake -- and while it's fun to watch, and I can't resist sharing a few words about it from time to time, I'm pretty happy to stay back in the cheap seats, where I'm not going to be crushed when the roof caves in.
So what was pitched and touted by the newsletter pundits last week?
We started things off, way back on Monday, with a look a different "urgent Monday buy" Motley Fool tease -- that was a microcap idea, so it was hinted as a 865X growth idea instead of just 85X today ... my story last week was mostly guessing, but we had a good discussion, just click here for that one.
And we stuck to that microcap theme on Tuesday -- Dylan Jovine was touting his #1 microcap for February, and it also happened to be one of those "heavily shorted" ideas that got a lot of attention this week -- my story on that is here.
Next to chime in was Jimmy Mengel, going more "mega-cap" with his pitch about a "God Chip" and the dreams that a new technology kissed by MIT and DARPA will generate 12,795% returns... Thinkolator results here for that one.
Michael popped by with another COVID-19 update in his latest Doc Gumshoe column as well -- hope, faccine, treatments, scary virus variants? His take is here.
And for the Friday File, I couldn't resist a bit of a screed about the GameStop (GME) silliness, but we can quickly move past that â I also added a couple new buys this week, and started with the Real Money Portfolio Annual Review, in which Iâll summarize my thoughts and a buy/sell opinion on every stock in the portfolio⦠details below...
